SCHEDULE 13G/A
Statement of Beneficial Ownership
C4 Therapeutics, Inc. Filed Acc 0002050709-26-000030
Stakes reported in this filing
| Reporting person | Shares | Of the class |
|---|---|---|
| Squadron Master Fund LP | 9,718,683 | 7.9% |
| Squadron Capital Management LLC | 9,718,683 | 7.9% |
| Matthew Sesterhenn | 9,718,683 | 7.9% |
| William Blank | 9,718,683 | 7.9% |
Members of a group can each report the same shares, so these rows overlap and don't add up.
Stake history · largest stake in each 13D and 13G
Loading xslSCHEDULE_13G_X02/primary_doc.xml…